drugset / Trial / NCT02041910
Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia
RandomizedSingle-groupOpen-labelTreatment
Summary
Azoospermia is defined as the complete lack of sperm in the ejaculate. In humans, Azoospermia affects about 1% of the male population and may be seen in up to 20% of male infertility situations. In testicular Azoospermia the testes are abnormal, atrophic, or absent, and sperm production severely disturbed to absent. FSH levels tend to be elevated (hypergonadotropic) as the feedback loop is interrupted. The condition is seen in 49-93% of men with Azoospermia. The purpose of this study is to assess the ability of bone marrow derived stem cells to differentiate into germ cells and their role in treatment of testicular Azoospermia
Timeline
- Start
- 2014-01
- Primary completion
- 2015-01
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rexlemestrocel-L | Cell therapy | 5 ml | Other |
| Subject | Rexlemestrocel-L | Cell therapy | 3e+06 cells | Other |
| Subject | Rexlemestrocel-L | Cell therapy | 5e+06 cells | Other |